Literature DB >> 12717387

Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.

Elke Ueberham1, Rainer Löw, Uwe Ueberham, Kai Schönig, Hermann Bujard, Rolf Gebhardt.   

Abstract

Based on the tetracycline-regulated gene expression system, a double-transgenic mouse model for liver fibrosis was established in which the expression of transforming growth factor beta1 (TGF-beta1) can be regulated deliberately by addition or removal of doxycycline hydrochloride to the drinking water. TGF-beta1 plasma levels in induced double-transgenic mice reached values ranging from 250 to 1,200 ng/mL, being 10 to 30 times above the normal plasma levels. By applying a cyclic induction-deinduction protocol, deleterious effects of the high plasma TGF-beta1 levels were overcome. By using this protocol, liver fibrosis occurred within a few cycles and progressed further to an intermediary fibrosis when cyclic induction was continued. On histochemical staining, a marked perisinusoidal deposition of extracellular matrix was detected accompanied by the activation of hepatic stellate cells as shown by alpha-smooth muscle actin (alpha-SMA) expression. Apoptosis of hepatocytes was prominent in TGF-beta1 high producers, leading to a decreasing number of TGF-beta1-expressing cells with time. No compensatory proliferation of hepatocytes could be detected. In advanced stages, fibrogenesis could be stopped by switching off TGF-beta1 production and reversal of fibrosis could be shown by (immuno)histochemistry within 6 to 21 days. Determination of messenger RNA (mRNA) levels of procollagen I and III, laminin (B1), matrix metalloproteinase (MMP)-2, -9, and -13, and tissue inhibitor of matrix metalloproteinase (TIMP)-1 and -2 by real-time reverse-transcription polymerase chain reaction (RT-PCR) provided insight into some mechanistic details of the fibrogenic process and its reversal. In conclusion, this model will enable the analysis of fibrogenesis at progressive stages and help in elucidating the cellular changes during development and regression of liver fibrosis caused by elevated TGF-beta1 expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717387     DOI: 10.1053/jhep.2003.50196

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  57 in total

1.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice.

Authors:  Wen-Ling Kuo; Ming-Chin Yu; Ju-Fang Lee; Chi-Neu Tsai; Tse-Ching Chen; Miin-Fu Chen
Journal:  J Gastrointest Surg       Date:  2011-11-09       Impact factor: 3.452

3.  Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.

Authors:  Yu-An Yang; Gen-Mu Zhang; Lionel Feigenbaum; Ying E Zhang
Journal:  Cancer Cell       Date:  2006-06       Impact factor: 31.743

4.  Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression.

Authors:  Sang Hwa Lee; Sung-Im Do; Hyun-Soo Kim
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

5.  Enhanced matrix degradation after withdrawal of TGF-beta1 triggers hepatocytes from apoptosis to proliferation and regeneration.

Authors:  E Arendt; U Ueberham; R Bittner; R Gebhardt; E Ueberham
Journal:  Cell Prolif       Date:  2005-10       Impact factor: 6.831

Review 6.  Antifibrotic therapies in the liver.

Authors:  W Z Mehal; D Schuppan
Journal:  Semin Liver Dis       Date:  2015-05-14       Impact factor: 6.115

7.  Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis.

Authors:  Ying Qu; Lei Zong; Mingyi Xu; Yuwei Dong; Lungen Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 8.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

9.  Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats.

Authors:  Shyr-Ming Sheen-Chen; Chung-Ren Lin; Kuan-Hung Chen; Chien-Hui Yang; Chien-Te Lee; Hui-Wen Huang; Chun-Ying Huang
Journal:  J Gastroenterol       Date:  2013-10-06       Impact factor: 7.527

10.  Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis.

Authors:  Qing-He Nie; Chuan-Long Zhu; Ya-Fei Zhang; Jie Yang; Jiu-Cong Zhang; Ren-Tao Gao
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.